YKL-40 is a novel biomarker for predicting hypertension incidence among prehypertensive subjects: A population-based nested case-control study in China.

Tian Xu,Chongke Zhong,Aili Wang,Zhirong Guo,Xiaoqing Bu,Yipeng Zhou,Yunfan Tian,Xinfeng HuangFu,Zhengbao Zhu,Yonghong Zhang
DOI: https://doi.org/10.1016/j.cca.2017.08.003
IF: 6.314
2017-01-01
Clinica Chimica Acta
Abstract:•YKL-40 was positively associated with hypertension incidence among prehypertensive subjects.•YKL-40 is a novel biomarker for predicting hypertension in prehypertension population.•Lowering YKL-40 may be beneficial to slow down the development from prehypertension to hypertension.
What problem does this paper attempt to address?